Cardiovascular effects of a mu-selective opioid agonist (tyrosine-D-arginine-phenylalanine-lysine-NH2) in fetal sheep: sites and mechanisms of action.

MLA

Holsey, Yasmin S., et al. “Cardiovascular Effects of a Mu-Selective Opioid Agonist (Tyrosine-D-Arginine-Phenylalanine-Lysine-NH2) in Fetal Sheep: Sites and Mechanisms of Action.” American Journal of Obstetrics & Gynecology, vol. 180, no. 5, May 1999, pp. 1127–30. EBSCOhost, https://doi.org/10.1016/S0002-9378(99)70605-8.

APA

Holsey, Y. S., Dunli Wu, Holsey, Y. S., Wu, D., Soong, Y., Omoniyi, A. T., & Szeto, H. H. (1999). Cardiovascular effects of a mu-selective opioid agonist (tyrosine-D-arginine-phenylalanine-lysine-NH2) in fetal sheep: sites and mechanisms of action. American Journal of Obstetrics & Gynecology, 180(5), 1127–1130. https://doi.org/10.1016/S0002-9378(99)70605-8

Chicago

Holsey, Yasmin S., Dunli Wu, Y S Holsey, D Wu, Y Soong, A T Omoniyi, and H H Szeto. 1999. “Cardiovascular Effects of a Mu-Selective Opioid Agonist (Tyrosine-D-Arginine-Phenylalanine-Lysine-NH2) in Fetal Sheep: Sites and Mechanisms of Action.” American Journal of Obstetrics & Gynecology 180 (5): 1127–30. doi:10.1016/S0002-9378(99)70605-8.